Cystic fibrosis transmembrane conductance regulator — Drug Target

All drugs that target Cystic fibrosis transmembrane conductance regulator — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]

Marketed (3)

• Trikafta (Copackaged) · Vertex Pharms Inc · Respiratory
  Trikafta works by correcting the faulty protein that causes cystic fibrosis, allowing the body to produce normal amounts of mucus.
• Kalydeco · Vertex Pharms Inc · Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] · Respiratory
  Kalydeco works by helping the defective protein in cystic fibrosis cells function more normally.
• Kalydeco · Concert Pharmaceuticals · Respiratory